Disease/Infection News

RSS

Study offers insight into handling the COVID-19 pandemic with biased data

Accurate and near real-time data on the course and evolution of the COVID-19 pandemic have been instrumental in informing public health mitigation strategies and policy worldwide.

22 Oct 2021

New AI-based tool helps clinicians understand and better predict adverse effects of COVID-19

The symptoms and side effects of Covid-19 are scattered across a diagnostic spectrum. Some patients are asymptomatic or experience a mild immune response, while others report significant long-term illnesses, lasting complications, or suffer fatal outcomes.

22 Oct 2021

SARS-CoV-2 cocktail with three antibodies potent in preclinical testing

Amidst growing concerns on the use and potential benefits of convalescent plasma therapy, a research group in the United States has identified three human antibodies (Abs) that, when combined, demonstrate both robust viral suppressive properties against all tested severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) Variants of Concern (VoC) in vitro and profound antiviral efficacy in vivo.

22 Oct 2021

Vaccinating adolescents may reduce the impact of COVID-19, according to a UK modeling study

A recent study from the United Kingdom, published in the open-access journal Vaccines, implies that vaccinating adolescents and children may be pivotal in reducing infections with the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), as well as ensuing coronavirus disease (COVID-19) morbidity and mortality across all age groups.

21 Oct 2021

STI and HIV services in crisis pregnancy centers could cause real harm to public health

Cases of sexually transmitted infections (STIs) and HIV are again on the rise in the U.S., giving new urgency to ongoing efforts to make STI and HIV services more accessible.

21 Oct 2021

Honeybees can be trained to identify SARS-CoV-2 infected samples, say scientists

In a recent study published on the bioRxiv* pre-print server, researchers from the Netherlands successfully trained honeybees (Apis mellifera) to identify severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infected minks (Neovison vison) using Pavlovian conditioning protocols.

21 Oct 2021

Investigational inhaled COVID-19 treatment graduates to phase 3 in ACTIV-2 trial

The AIDS Clinical Trials Group, the largest global HIV research network, which recently expanded its focus to include evaluating outpatient treatment for COVID-19, today announced that the external data and safety monitoring board (DSMB) has recommended that SNG001, an inhaled formulation of interferon beta, advance to phase 3 in the ACTIV-2 Outpatient Monoclonal Antibodies and Other Therapies Trial (ACTG A5401).

21 Oct 2021

Nationwide advertising campaign launches in the UK to urge people to get COVID-19 booster, flu jabs

A nationwide advertising campaign launches today (Friday 22 October) as part of the government's call to the public to get their COVID-19 booster and flu jabs, to protect themselves and their loved ones this winter.

21 Oct 2021

Novel trial uses a virtual village to treat HIV-associated loneliness

A new clinical trial designed by Maile Young Karris, MD, internal medicine physician and infectious disease specialist at UC San Diego Health, seeks to discover whether people living with HIV can benefit from emotional support offered by a virtual community, and from physical support and services delivered by community volunteers.

21 Oct 2021

Antisocial and prosocial behavior during COVID-19

A new study aims to determine whether individuals with antisocial behaviors are more susceptible to COVID-19.

21 Oct 2021

Comparative effectiveness of ChAdOx1 and BNT162b2 COVID-19 vaccines

In a recent study, researchers compared the efficacy of the Pfizer-BioNTech and Oxford-AstraZeneca COVID-19 vaccines against infection SARS-CoV-2.

21 Oct 2021

Comparison of social distancing policies in Denmark and Sweden to combat COVID-19

The current study included the national response of Denmark and Sweden to the COVID-19 pandemic.

21 Oct 2021

Influence of age on innate and adaptive immunity in COVID-19 patients

A new study investigates how age influences SARS-CoV-2 replication, innate and adaptive immune responses.

21 Oct 2021

U.S. life expectancy may drop for the second year, minorities most affected

Scientists estimate the effect of the pandemic on life expectancy at birth, at 65 years overall, as well as for individual populations.

21 Oct 2021

Duke awarded NIAID funding to develop the next generation of pan-coronavirus vaccines

The National Institute of Allergy and Infectious Diseases has awarded $17.5 million over three years to the Duke Human Vaccine Institute to develop a vaccine that protects against multiple types of coronaviruses and viral variants.

21 Oct 2021

Booster dose of COVID-19 vaccine significantly increases neutralizing antibodies in rhesus macaques

A booster dose of the mRNA-1273 COVID-19 vaccine given to rhesus macaques about six months after their primary vaccine series significantly increased levels of neutralizing antibodies against all known SARS-CoV-2 variants of concern, according to a new study from National Institutes of Health scientists and colleagues.

21 Oct 2021

Novel Einstein-developed strategy successfully suppresses HIV infections in mice

Armed with a novel strategy they developed for bolstering the body's immune response, scientists at Albert Einstein College of Medicine have successfully suppressed HIV infections in mice-;offering a path to a functional cure for HIV and other chronic viral infections.

21 Oct 2021

Disease/Infection News

Study offers insight into handling the COVID-19 pandemic with biased data

New AI-based tool helps clinicians understand and better predict adverse effects of COVID-19

SARS-CoV-2 cocktail with three antibodies potent in preclinical testing

Vaccinating adolescents may reduce the impact of COVID-19, according to a UK modeling study

STI and HIV services in crisis pregnancy centers could cause real harm to public health

Honeybees can be trained to identify SARS-CoV-2 infected samples, say scientists

Investigational inhaled COVID-19 treatment graduates to phase 3 in ACTIV-2 trial

Nationwide advertising campaign launches in the UK to urge people to get COVID-19 booster, flu jabs

Novel trial uses a virtual village to treat HIV-associated loneliness

Antisocial and prosocial behavior during COVID-19

Comparative effectiveness of ChAdOx1 and BNT162b2 COVID-19 vaccines

Comparison of social distancing policies in Denmark and Sweden to combat COVID-19

Influence of age on innate and adaptive immunity in COVID-19 patients

U.S. life expectancy may drop for the second year, minorities most affected

Duke awarded NIAID funding to develop the next generation of pan-coronavirus vaccines

Booster dose of COVID-19 vaccine significantly increases neutralizing antibodies in rhesus macaques

Novel Einstein-developed strategy successfully suppresses HIV infections in mice

Study: Covid-19 vaccine is over 90% effective at preventing deaths from Delta

EKF Diagnostics to showcase at Medica 2021 STAT-Site® WB β-ketone and glucose handheld analyzer live & in person

How has COVID-19 increased plastic pollution?

Decoding Cannabis: Differentiating Hemp and Marijuana

Deciphering the Microbiome with The Microsetta Initiative

Leveraging the power of automation to boost research

Latest News